SCHEMBL27119544

SCHEMBL27119544

NNC(=O)c1cc2c(cc1F)SCC(NC(=O)O)C(=O)N2

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 9/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ GLA P06280 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961944 1.00 CRBN (0.37) CRBNSMN1; SMN2KDM4EHDAC1HDAC8
SCHEMBL29797018 0.84 GAA (0.38) CRBNHDAC1HDAC8HDAC6
SCHEMBL26961679 0.84 GAA (0.38) CRBNHDAC1HDAC8HDAC6
SCHEMBL27125391 0.83 KDM4E (0.33) CRBNSMN1; SMN2KDM4EHDAC1HDAC8
SCHEMBL26962775 0.83 KDM4E (0.33) CRBNSMN1; SMN2KDM4EHDAC1HDAC8
SCHEMBL26962754 0.81 HDAC1 (0.44) SMN1; SMN2KDM4EHDAC1HDAC8HDAC6
SCHEMBL30830368 0.79 HDAC1 (0.33) CRBNSMN1; SMN2HDAC1HDAC8HDAC6
SCHEMBL27121024 0.74 GAA (0.40) CRBNSMN1; SMN2POLB
SCHEMBL20263999 0.74 GAA (0.40) CRBNSMN1; SMN2POLB
SCHEMBL30675755 0.73 HDAC1 (0.51) CRBNHDAC1HDAC8HDAC6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback